Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma.

Ashida, Atsuko; Sakaizawa, Kaori; Mikoshiba, Asuka; Kiniwa, Yukiko; Okuyama, Ryuhei

Ashida, Atsuko; Sakaizawa, Kaori; Mikoshiba, Asuka; Kiniwa, Yukiko; Okuyama, Ryuhei.

Affiliation

Ashida A; Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.

Acta Derm Venereol ; 99(12): 1184-1185, 2019 Nov 01.

Article in En | MEDLINE | ID: mdl-31396634

Subject(s)

Biomarkers, Tumor/blood; Circulating Tumor DNA/blood; Melanoma/blood; Skin Neoplasms/blood; Tumor Burden; Adult; Aged; Antineoplastic Agents/adverse effects; Biomarkers, Tumor/genetics; Circulating Tumor DNA/genetics; Female; Genetic Predisposition to Disease; Humans; L-Lactate Dehydrogenase/blood; Male; Melanoma/drug therapy; Melanoma/genetics; Melanoma/pathology; Mutation; Phenotype; Proto-Oncogene Proteins B-raf/genetics; Skin Neoplasms/drug therapy; Skin Neoplasms/genetics; Skin Neoplasms/pathology; Time Factors; Treatment Outcome

Key words

BRAF; LDH; circulating tumor DNA; melanoma; biomarker

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Biomarkers, Tumor / Tumor Burden / Circulating Tumor DNA / Melanoma Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Acta Derm Venereol Year: 2019 Document type: Article Affiliation country: Japan Country of publication: Sweden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google